Global Intravenous Securement Device Market Size By Type (Medical Tape, Others), By Application (Hospitals And Clinics, Homecare), By Region, And Segment Forecasts, 2023 to 2032

The Global Intravenous (IV) Securement Device Market was valued at USD 1.3 billion in 2023 and is projected to reach USD 2.4 billion by 2031, growing at a CAGR of 8.1% during the forecast period from 2023 to 2031. The market is experiencing robust growth due to the increasing incidence of chronic illnesses, rising surgical procedures, and the growing use of intravenous therapy across healthcare settings. IV securement devices play a critical role in ensuring the stability of catheters and reducing the risk of complications such as dislodgement, phlebitis, and infections.

Drivers:

1. Rising Hospitalization and IV Therapy Usage:

Growing global hospitalization rates and the routine use of intravenous catheters in patient care are boosting the demand for securement solutions that reduce catheter-related complications.

2. Increased Focus on Infection Prevention:

Infection control has become a key priority in healthcare systems. IV securement devices help lower the risk of central line-associated bloodstream infections (CLABSIs), promoting their adoption.

3. Technological Advancements in Medical Adhesives and Materials:

Modern securement devices are designed with advanced, skin-friendly adhesives and breathable materials that enhance patient comfort and device efficacy.

Restraints:

1. High Cost of Advanced Securement Devices:

The cost of high-performance IV securement devices can be a limiting factor, particularly in resource-constrained healthcare settings and emerging economies.

2. Lack of Standardized Protocols Across Facilities:

Variation in catheter management protocols and lack of awareness in some regions can hinder the consistent use of securement devices.

Opportunity:

1. Expansion in Emerging Healthcare Markets:

Countries across Asia-Pacific, Latin America, and the Middle East are investing in healthcare infrastructure, which presents a lucrative opportunity for IV securement device manufacturers.

2. Development of All-in-One Securement Solutions:

The trend toward integrated and user-friendly securement devices that simplify catheter stabilization and maintenance presents major growth potential.

Market by System Type Insights:

Based on system type, the Peripheral Intravenous Securement Devices segment accounted for the largest share in 2023. These devices are widely used in general medical wards due to their cost-effectiveness and compatibility with short-term therapies. However, Central Venous Catheter Securement Devices are expected to grow at the fastest rate, supported by increasing use in intensive care and oncology units where infection prevention is crucial.

Market by End-use Insights:

By end use, Hospitals dominated the market in 2023, contributing over 60% of total revenue. This is due to the high volume of IV insertions and stringent infection control policies in hospitals. The Home Healthcare segment is anticipated to grow rapidly, driven by the rising trend of outpatient and at-home intravenous therapy for chronic disease management.

Market by Regional Insights:

North America held the largest share of the global market in 2023, attributed to advanced healthcare infrastructure, high awareness of infection control, and reimbursement support. Asia-Pacific is projected to witness the highest CAGR during the forecast period due to improving healthcare access, expanding hospital networks, and growing awareness about IV-related complications.

Competitive Scenario:

Leading companies in the global intravenous securement device market include 3M Company, Becton, Dickinson and Company (BD), Cardinal Health, Smiths Medical, Medline Industries, Inc., M.C. Johnson Company, Inc., TIDI Products LLC, ConvaTec Group PLC, and Dermarite Industries LLC. These players are focusing on product innovation, strategic acquisitions, and market expansion to strengthen their foothold.

In 2023, BD launched a new line of securement devices optimized for pediatric patients, combining skin-friendly materials and enhanced securement strength.

3M enhanced its Tegaderm™ portfolio with antimicrobial properties in 2024, aiming to reduce CLABSI risks in critical care units.

Scope of Work – Global Intravenous Securement Device Market

Report Metric Details

Market Size (2023) USD 1.3 billion

Projected Market Size (2031) USD 2.4 billion

CAGR (2023–2031) 8.1%

Market Segments By System Type, End-use, Region

Growth Drivers Infection control focus, rising IV use, hospital demand

Opportunities Emerging markets, all-in-one device innovations

Key Market Developments:

April 2024: 3M introduced a next-generation IV securement device with breathable, antimicrobial film designed to improve wear time and reduce infection rates.

January 2024: Smiths Medical partnered with a hospital group in Southeast Asia to expand its securement device adoption in intensive care units.

July 2023: Cardinal Health enhanced its product range with eco-friendly, latex-free securement devices to meet sustainability goals.

FAQs:

1) What is the current market size of the Global Intravenous Securement Device Market?

The market size was USD 1.3 billion in 2023.

2) What is the major growth driver of the Global Intravenous Securement Device Market?

The key driver is the rising adoption of IV therapy and increasing focus on infection control.

3) Which is the largest region during the forecast period in the Global Intravenous Securement Device Market?

North America is expected to remain the largest regional market.

4) Which segment accounted for the largest market share in the Global Intravenous Securement Device Market?

Peripheral Intravenous Securement Devices held the largest share in 2023.

5) Who are the key market players in the Global Intravenous Securement Device Market?

Key players include 3M, BD, Cardinal Health, Smiths Medical, and Medline Industries.